Diet with adequate copper and iron intake improves MAFLD management
A recent study by Journal of Nutritional Science found the intricate relationship between nutrition and health, the results uncovered compelling evidence linking micronutrient intake to Metabolic-associated Fatty Liver Disease (MAFLD).
The study was conducted as a cross-sectional analysis based on data from the National Health and Nutrition Examination Survey (NHANES) and aimed to explore the association between specific micronutrients and MAFLD, a term introduced in 2020 to replace Non-Alcoholic Fatty Liver Disease (NAFLD).
The research included 5,976 participants and revealed intriguing insights into the impact of copper and iron intake on MAFLD. After meticulous adjustment for potential confounding factors, the results indicated a substantial association between higher copper intake and a reduced risk of MAFLD. Also, participants in quartiles Q3 and Q4 for copper intake demonstrated significantly lower odds of MAFLD, with odds ratios of 0.68 (95% CI 0.50, 0.93) and 0.60 (95% CI 0.45, 0.80) respectively.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.